
Hetrombopag
CAS No. 2114365-78-3
Hetrombopag( —— )
Catalog No. M13363 CAS No. 2114365-78-3
Hetrombopag is a potent, selective, orally-active Thrombopoietin (TPO) receptor agonist.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 485 | Get Quote |
![]() ![]() |
50MG | 2507 | Get Quote |
![]() ![]() |
100MG | 3168 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameHetrombopag
-
NoteResearch use only, not for human use.
-
Brief DescriptionHetrombopag is a potent, selective, orally-active Thrombopoietin (TPO) receptor agonist.
-
DescriptionHetrombopag is a potent, selective, orally-active Thrombopoietin (TPO) receptor agonist; specifically stimulates proliferation and/or differentiation of human TPOR-expressing cells, including 32D-MPL and human hematopoietic stem cells, with low nanomolar EC50 values through stimulation of STAT, PI3K and ERK signalling pathways; specifically enhances the viability and promoted the growth of 32D-MPL cells in hollow fibres implanted in nude mice, exhibiting much higher potency than eltrombopag in vivo.Other Indication Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetCD110
-
RecptorCD110
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number2114365-78-3
-
Formula Weight458.474
-
Molecular FormulaC25H22N4O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMF : 6.25 mg/mL (13.63 mM)
-
SMILESCC1=C(C(=O)N(N1)C2=CC3=C(CCCC3)C=C2)N=NC4=CC=CC(=C4O)C5=CC=C(O5)C(=O)O
-
Chemical Name5-[(5E)-5-[[5-methyl-3-oxo-2-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-pyrazol-4-yl]hydrazinylidene]-6-oxocyclohexa-1,3-dien-1-yl]furan-2-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhou N, et al. Cardiovasc Drugs Ther. 2016 Dec;30(6):567-577.
2. Xie C, et al. J Cell Mol Med. 2018 Nov;22(11):5367-5377.
molnova catalog



related products
-
Lusutrombopag
An orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist.
-
Hetrombopag
Hetrombopag is a potent, selective, orally-active Thrombopoietin (TPO) receptor agonist.